https://www.colloidalsilverkillsviruses.com/
https://thesilveredge.com/colloidal-silver-stops-monkeypox-virus-and-smallpox-virus/
For example, according to a clinical lab study published in volume 3, number 4, April 2008 edition of Nanoscale Research Letters, very small silver particles (10 nm in size) significantly inhibited the infectivity of the Monkeypox virus.
The study was conducted in conjunction with the Applied Biotechnology Branch, Human Effectiveness Directorate of Wright-Patterson Air Force Base in Ohio. The study’s authors concluded:
“These results demonstrate that silver-based nanoparticles of approximately 10 nm inhibit Monkey Pox Virus infection in vitro, supporting their potential use as an anti-viral therapeutic.”
In other words, the researchers are basically saying that silver’s effectiveness against an exotic animal virus like the one that causes Monkeypox clearly demonstrates that it should further be investigated as a therapeutic antiviral agent.
Another Study: Nanosilver Inhibits
MonkeyPox Plaque Formation
Another clinical lab study, published in 2008 in the journal Nanoscale Research Letters, was titled “A Preliminary Assessment of Silver Nanoparticle Inhibition of Monkeypox Virus Plaque Formation.”
In this in vitro (i.e., test tube) study, researchers used the monkeypox virus Zaire strain, which was originally obtained from a fatally infected human in Zaire and shown to be fatal in monkeys, as well. The virus was tested under biosafety level 3 conditions in order to prevent infection of the researchers.